Wize Pharma, Inc. Business Operations Contracts & Agreements
24 Contracts & Agreements
- Agency Agreements (1 contract)
- Development Agreements (7)
- Distribution Agreements (3)
- Sales Agreements (3)
- Services Agreements (6)
- Supply Agreements (1)
- Termination Agreements (2)
- Voting Agreements (1)
- Redacted Agreement between Mawson Hosting LLC and BE Global Development Limited (Filed With SEC on August 12, 2024)
- Service Framework Agreement between Mawson Hosting LLC and CTG Colocation PA LLC, dated October 12, 2023 (Filed With SEC on April 1, 2024)
- Service Framework Agreement between Mawson Hosting LLC and CTG Colocation PA LLC, dated October 12, 2023 (Filed With SEC on October 23, 2023)
- Service Framework Agreement between Mawson Hosting LLC and CTG Colocation PA LLC, dated October 12, 2023 (Filed With SEC on October 19, 2023)
- Electricity Supply Agreement between MIG No.1 Pty Ltd and Cape Byron Management Pty Ltd dated October 22, 2021 (Filed With SEC on October 22, 2021)
- International Sales Contract No. ZY0220211229 between Mawson Infrastructure Group Pty Ltd and Canaan Convey Co. Ltd (Filed With SEC on August 12, 2021)
- Amendment to Exclusive Distribution and Licensing Agreement by and between Wize Pharma Ltd., OcuWize Ltd. and Resdevco Research and Development Company Ltd., dated May 4, 2020 (Filed With SEC on July 27, 2021)
- International Sales Contract NoZY0220211163 between Cosmos Infrastructure LLC and Canaan Convey Co., Ltd. dated March 26, 2021 (Filed With SEC on May 19, 2021)
- International Sales Contract No:ZY0220211061 between Cosmos Infrastructure LLC and Canaan Convey Co., Ltd. dated February 5, 2021 (Filed With SEC on May 19, 2021)
- Amendment to Exclusive Distribution and Licensing Agreement by and between Wize Pharma Ltd., OcuWize Ltd. and Resdevco Research and Development Company Ltd., dated May 4, 2020 (Filed With SEC on March 1, 2021)
- Memorandum of Understanding between Wize Pharma Ltd. and Resdevco, Research and Development Ltd. dated February 24, 2019 (Filed With SEC on March 30, 2020)
- Memorandum of Understanding between Wize Pharma Ltd. and Resdevco, Research and Development Ltd. dated February 24, 2019 (Filed With SEC on April 1, 2019)
- Placement Agency Agreement (Filed With SEC on October 23, 2018)
- Memorandum of Understanding by and between Wize Pharma Ltd. and Resdevco Research and Development Company Ltd., dated January 8, 2018 (Filed With SEC on March 29, 2018)
- Third Amendment to Exclusive Distribution and Licensing Agreement by and between Wize Pharma Ltd. and Resdevco Research and Development Company Ltd., dated December 26, 2017 (Filed With SEC on March 29, 2018)
- Agreement for Provision of Services Agreement dated September 30, 2015 between Wize Pharma Ltd. and Ron Mayron (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)
- Agreement for Provision of Services Agreement dated September 30, 2015 between Wize Pharma Ltd. and N Danenberg Holdings (2000) Ltd. (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)
- Appendix G to Exclusive Distribution and Licensing Agreement between Resdevco Ltd. and Wize Pharma Ltd. signed on May 1, 2015 dated July 20, 2017 (Filed With SEC on July 27, 2017)
- Appendix F to Exclusive Distribution and Licensing Agreement between Resdevco Ltd. and Wize Pharma Ltd. signed on May 1, 2015 dated July 20, 2017 (Filed With SEC on July 27, 2017)
- Exclusive Distribution and Licensing Agreement dated May 1, 2015 between Resdevco Ltd. and Wize Pharma Ltd. (formerly Star Night Technologies Ltd.) (Filed With SEC on July 27, 2017)
- Form of Termination of Services Agreement (Filed With SEC on May 22, 2017)
- Form of Termination of License Agreement (Filed With SEC on May 22, 2017)
- Voting and Undertaking Agreement, dated as of May 21, 2017, by and among OphthaliX, Inc., Wize Pharma Ltd., and Can-Fite BioPharma Ltd (Filed With SEC on May 22, 2017)
- SERVICES AGREEMENT (Filed With SEC on November 23, 2011)
